Multi-Omics Reveals Early Pregnancy Placental Dysfunction Associated With Preterm and Term Preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Genomics and Molecular Biology

Background:

• Preeclampsia affects 2-8% of human pregnancies globally.
• Placental dysfunction is central to preeclampsia pathogenesis.
• Early pregnancy molecular aberrations underlying preeclampsia remain poorly understood.

Purpose of the Study:

• To comprehensively analyze early pregnancy placental molecular signatures in preeclampsia.
• To differentiate molecular pathways associated with preterm versus term preeclampsia.
• To identify novel biomarkers and therapeutic targets for preeclampsia.

Main Methods:

• Multi-omics analysis of early pregnancy placental biopsies (chorionic villus samples).
• Integrative multivariate statistical approaches.
• Validation of key gene expression findings (e.g., melanophilin).

Main Results:

• Distinct molecular signatures identified for preterm and term preeclampsia.
• Preterm preeclampsia associated with dysregulated lipoprotein metabolism.
• Term preeclampsia linked to inflammatory pathways, Notch/Kit signaling, and ribosome assembly.
• Melanophilin downregulation in early placenta linked to term preeclampsia via syncytiotrophoblast dysfunction.

Conclusions:

• Early placental molecular profiles differ significantly between preterm and term preeclampsia.
• Findings challenge the notion that term preeclampsia is unrelated to early placental dysfunction.
• Identified molecular signatures and melanophilin offer potential for predictive biomarkers and targeted treatments for preeclampsia.